1	Binding	binding	_	_	_	_	_	_	_
2	characteristics	characteristic	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	blood	blood	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	multiple	multiple	_	_	_	_	_	_	_
13	sclerosis	sclerosis	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	exact	exact	_	_	_	_	_	_	_
4	etiology	etiology	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	multiple	multiple	_	_	_	_	_	_	_
7	sclerosis	sclerosis	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	MS	MS	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	remains	remain	_	_	_	_	_	_	_
12	unresolved	unresolved	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	immune	immune	_	_	_	_	_	_	_
15	reactions	reaction	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	believed	believe	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	central	central	_	_	_	_	_	_	_
22	pathogenic	pathogenic	_	_	_	_	_	_	_
23	mechanisms	mechanism	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Endogenous	endogenous	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	therapeutic	therapeutic	_	_	_	_	_	_	_
4	steroid	steroid	_	_	_	_	_	_	_
5	hormones	hormone	_	_	_	_	_	_	_
6	affect	affect	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	immune	immune	_	_	_	_	_	_	_
9	system	system	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	inflammatory	inflammatory	_	_	_	_	_	_	_
13	diseases	disease	_	_	_	_	_	_	_
14	are	be	_	_	_	_	_	_	_
15	associated	associate	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
21	axis	axis	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	providing	provide	_	_	_	_	_	_	_
24	evidence	evidence	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	an	an	_	_	_	_	_	_	_
27	immune-endocrine	immune-endocrine	_	_	_	_	_	_	_
28	interplay	interplay	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Function	function	_	_	_	_	_	_	_
2	tests	test	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	MS	ms	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	revealed	reveal	_	_	_	_	_	_	_
7	dysregulation	dysregulation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
11	system	system	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	substantial	substantial	_	_	_	_	_	_	_
15	proportion	proportion	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	patients	patient	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	characterized	characterize	_	_	_	_	_	_	_
3	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	GR	GR	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	peripheral	peripheral	_	_	_	_	_	_	_
11	blood	blood	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	39	39	_	_	_	_	_	_	_
15	MS	MS	_	_	_	_	_	_	_
16	patients	patient	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	14	14	_	_	_	_	_	_	_
19	age-	age-	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	sex-matched	sex-matched	_	_	_	_	_	_	_
22	controls	control	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	respect	respect	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	dissociation	dissociation	_	_	_	_	_	_	_
27	constant	constant	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	capacity	capacity	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	using	use	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	whole-cell	whole-cell	_	_	_	_	_	_	_
35	binding	binding	_	_	_	_	_	_	_
36	assay	assay	_	_	_	_	_	_	_
37	with	with	_	_	_	_	_	_	_
38	[	[	_	_	_	_	_	_	_
39	3H]dexamethasone	3H]dexamethasone	_	_	_	_	_	_	_
40	as	as	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	ligand	ligand	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	GR	GR	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	parameters	parameter	_	_	_	_	_	_	_
4	did	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	differ	differ	_	_	_	_	_	_	_
7	significantly	significantly	_	_	_	_	_	_	_
8	between	between	_	_	_	_	_	_	_
9	patients	patient	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	Kd	Kd	_	_	_	_	_	_	_
12	8.98	8.98	_	_	_	_	_	_	_
13	+/-	+/-	_	_	_	_	_	_	_
14	1.07	1.07	_	_	_	_	_	_	_
15	nM	nM	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	Bmax	Bmax	_	_	_	_	_	_	_
18	183	183	_	_	_	_	_	_	_
19	+/-	+/-	_	_	_	_	_	_	_
20	29.8	29.8	_	_	_	_	_	_	_
21	fmol/mg	fmol/mg	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	controls	control	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	Kd	Kd	_	_	_	_	_	_	_
27	9.36	9.36	_	_	_	_	_	_	_
28	+/-	+/-	_	_	_	_	_	_	_
29	1.17	1.17	_	_	_	_	_	_	_
30	nM	nM	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	Bmax	Bmax	_	_	_	_	_	_	_
33	158	158	_	_	_	_	_	_	_
34	+/-	+/-	_	_	_	_	_	_	_
35	16	16	_	_	_	_	_	_	_
36	fmol/mg	fmol/mg	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	age	age	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	sex	sex	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	course	course	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	duration	duration	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	severity	severity	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	disease	disease	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	prior	prior	_	_	_	_	_	_	_
18	steroid	steroid	_	_	_	_	_	_	_
19	treatments	treatment	_	_	_	_	_	_	_
20	was	be	_	_	_	_	_	_	_
21	detected	detect	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	GR	GR	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	parameters	parameter	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	analyzed	analyze	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	relation	relation	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	results	result	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	combined	combined	_	_	_	_	_	_	_
14	dexamethasone-CRH	dexamethasone-crh	_	_	_	_	_	_	_
15	test	test	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	which	which	_	_	_	_	_	_	_
18	reflects	reflect	_	_	_	_	_	_	_
19	corticosteroid	corticosteroid	_	_	_	_	_	_	_
20	receptor	receptor	_	_	_	_	_	_	_
21	function	function	_	_	_	_	_	_	_
22	at	at	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	hypothalamus	hypothalamus	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	30	30	_	_	_	_	_	_	_
28	patients	patient	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	9	9	_	_	_	_	_	_	_
31	controls	control	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	While	while	_	_	_	_	_	_	_
2	controls	control	_	_	_	_	_	_	_
3	showed	show	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	moderate	moderate	_	_	_	_	_	_	_
6	correlation	correlation	_	_	_	_	_	_	_
7	between	between	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	affinity	affinity	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	GR	gr	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	lymphocytes	lymphocyte	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	regulatory	regulatory	_	_	_	_	_	_	_
17	function	function	_	_	_	_	_	_	_
18	at	at	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	hypothalamic	hypothalamic	_	_	_	_	_	_	_
21	level	level	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	patients	patient	_	_	_	_	_	_	_
25	did	do	_	_	_	_	_	_	_
26	not	not	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	physiological	physiological	_	_	_	_	_	_	_
7	relationship	relationship	_	_	_	_	_	_	_
8	between	between	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	function	function	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	disturbed	disturb	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	MS	MS	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

